Abstract:BackgroundParkinson's disease (PD) is characterized by dopaminergic neuronal loss in the substantia nigra pars compacta and intracellular inclusions called Lewy bodies (LB). During the course of disease, misfolded α-synuclein, the major constituent of LB, spreads to different regions of the brain in a prion-like fashion, giving rise to successive non-motor and motor symptoms. Etiology is likely multifactorial, and involves interplay among aging, genetic susceptibility and environmental factors.Main bodyThe prevalence of PD rises exponentially with age, and aging is associated with impairment of cellular pathways which increases susceptibility of dopaminergic neurons to cell death. However, the majority of those over the age of 80 do not have PD, thus other factors in addition to aging are needed to cause disease. Discovery of neurotoxins which can result in parkinsonism led to efforts in identifying environmental factors which may influence PD risk. Nevertheless, the causality of most environmental factors is not conclusively established, and alternative explanations such as reverse causality and recall bias cannot be excluded. The lack of geographic clusters and conjugal cases also go against environmental toxins as a major cause of PD. Rare mutations as well as common variants in genes such as SNCA, LRRK2 and GBA are associated with risk of PD, but Mendelian causes collectively only account for 5% of PD and common polymorphisms are associated with small increase in PD risk. Heritability of PD has been estimated to be around 30%. Thus, aging, genetics and environmental factors each alone is rarely sufficient to cause PD for most patients.ConclusionPD is a multifactorial disorder involving interplay of aging, genetics and environmental factors. This has implications on the development of appropriate animal models of PD which take all these factors into account. Common converging pathways likely include mitochondrial dysfunction, impaired autophagy, oxidative stress and neuroinflammation, which are associated with the accumulation and spread of misfolded α-synuclein and neurodegeneration. Understanding the mechanisms involved in the initiation and progression of PD may lead to potential therapeutic targets to prevent PD or modify its course.

Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches

Parkinson’s Disease: From Pathogenesis to Pharmacogenomics

Parkinson disease: from pathology to molecular disease mechanisms

Decoding the Role of Familial Parkinson’s Disease-Related Genes in DNA Damage and Repair

Gene–environment Interactions: Key to Unraveling the Mystery of Parkinson's Disease

Parkinson’s disease: etiopathogenesis and treatment

Signaling Pathways in Parkinson’s Disease: Molecular Mechanisms and Therapeutic Interventions

Genetic Insights into Sporadic Parkinson's Disease Pathogenesis

Key genes and convergent pathogenic mechanisms in Parkinson disease

An Update on Potential Therapeutic Strategies for Parkinson’s Disease Based on Pathogenic Mechanisms

The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease

Genetics in Parkinson’s disease, state-of-the-art and future perspectives

Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy

Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson's Disease

Molecular chaperones and Parkinson's disease

The genetic background of Parkinson's disease: current progress and future prospects

Cell biology of Parkinson's disease: Mechanisms of synaptic, lysosomal, and mitochondrial dysfunction

Emerging perspectives on precision therapy for Parkinson's disease: multidimensional evidence leading to a new breakthrough in personalized medicine

Uncovering the genetic basis of Parkinson's disease globally: from discoveries to the clinic

Identification of Parkinson's Disease-Causing Genes Via Omics Data.

Clinical Manifestations and Molecular Backgrounds of Parkinson's Disease Regarding Genes Identified From Familial and Population Studies